Delivery Order SPE2DB20D3103-SPE2DB21FQ1Z0
- Not listed
- This federal contract award is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,627.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of January 9, 2025. The contract is not set aside for any specific business designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,391,691 units of the drug XEOMIN (200 unit vials). The $7,181.44 firm fixed-price delivery order has a completion date of June 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $7,379.90 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has no set-aside designation and was awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,472.76 firm fixed-price delivery order is for the supply of 4,557,281,215 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the supply of XEOMIN 50 unit vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $2,850. It is a firm fixed-price delivery order contract with a completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XEOMIN 100 unit vials. The $10,484.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $5,242.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.40, is for the delivery of 4,566 units of XEOMIN 100 unit vials. This is a firm fixed-price delivery order contract with a completion date of November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $20,114.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and an ultimate completion date of February 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of 4,560,722,357 units of XEOMIN 200 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,290.88 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 25, 2023, with a completion date of May 16, 2023. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ1Z0Delivery Order
This federal contract award is for the delivery of 4,554,708,047 units of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $7,080.40 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also includes a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/8/21 |